Aligos Therapeutics Inc (ALGS): ALGS selects lead SARS-CoV-2 PI

Replies (1) Next 10 Prev Next

Send PM Follow Ignore

Re: DewDiligence post# 7

Monday, 04/04/2022 11:29:52 AM

Monday, April 04, 2022 11:29:52 AM

ALGS selects lead SARS-CoV-2 PI—phase-1 expected to start in early 2023 (or very late 2022):

https://finance.yahoo.com/news/aligos-therapeutics-selects-drug-candidate-120000412.html

The timing of this program was known from the Leerink webcast two months ago (#msg-167924816), so the only new news is that a lead compound has been selected.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Keep Last Read

Replies (1) Next 10 Prev Next

Go Ad-Free